Sernova Biotherapeutics Inc
SEOVF
$0.10
$0.003.43%
OTC PK
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 769.70K | 424.80K | 189.10K | 60.40K | 1.45M |
| Total Receivables | 85.40K | 92.60K | 87.50K | 192.20K | 313.30K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 259.70K | 54.50K | 96.30K | 108.40K | 347.70K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.11M | 571.90K | 373.00K | 361.10K | 2.11M |
|
|
|||||
| Total Current Assets | 1.11M | 571.90K | 373.00K | 361.10K | 2.11M |
| Net Property, Plant & Equipment | 6.50K | 9.80K | 12.60K | 135.20K | 534.50K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 165.00K | 159.70K | 161.80K | 162.00K |
| Total Assets | 1.12M | 746.70K | 545.30K | 658.10K | 2.80M |
|
|
|||||
| Total Accounts Payable | 3.68M | 13.29M | 12.61M | 14.22M | 13.72M |
| Total Accrued Expenses | 2.70M | 2.69M | 2.43M | 704.60K | 610.40K |
| Short-term Debt | -- | 2.85M | 2.66M | 2.64M | 2.47M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.63M | -- | -- | 45.70K | 80.40K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 8.00M | 18.83M | 17.70M | 17.61M | 16.87M |
|
|
|||||
| Total Current Liabilities | 8.00M | 18.83M | 17.70M | 17.61M | 16.87M |
| Long-Term Debt | 167.50K | 795.80K | 744.60K | 681.50K | 583.90K |
| Short-term Debt | -- | 2.85M | 2.66M | 2.64M | 2.47M |
| Capital Leases | -- | -- | -- | 23.50K | 296.90K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 8.17M | 19.62M | 18.44M | 18.31M | 17.76M |
|
|
|||||
| Common Stock & APIC | 108.36M | 104.82M | 100.25M | 100.46M | 100.39M |
| Retained Earnings | -125.47M | -124.18M | -118.53M | -118.43M | -115.67M |
| Treasury Stock & Other | 1.27M | 487.30K | 383.30K | 319.90K | 329.10K |
| Total Common Equity | -15.83M | -18.87M | -17.89M | -17.65M | -14.95M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 8.79M | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 8.79M | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -15.83M | -18.87M | -17.89M | -17.65M | -14.95M |
| Total Preferred Equity | 8.79M | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -7.05M | -18.87M | -17.89M | -17.65M | -14.95M |
|
|
|||||